Mr. Speaker, the reality is that this is a global environment that is extremely competitive as all companies ramp up their supply chains. We will receive six million doses of vaccines from Pfizer and Moderna prior to the end of the quarter and 20 million from approved vaccine suppliers prior to the end of Q2, and prior to the end of the third quarter all Canadians will have access to a vaccine should they want to. That is why people from around the globe and within Canada are hailing Canada's strategy relating to vaccines. I point to Professor Chagla; Professor Kindrachuk, an assistant professor at the University of Manitoba; as well as Lorian Hardcastle from the University of Calgary itself.
In the House of Commons on January 28th, 2021. See this statement in context.